Relationship between SP142 PD-L1 Expression and (18)F-FDG Uptake in Non-Small-Cell Lung Cancer

OBJECTIVES: Immune checkpoint blockers constitute the first-line treatment for advanced non-small-cell lung cancer (NSCLC) with ≥50% PD-L1 expression. In NSCLC, PD-L1 positivity is correlated with high (18)F-fluorodeoxyglucose ((18)F-FDG) uptake. However, these studies only included patients undergo...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Long, Liu, Jinjun, Shi, Jingyun, Wang, Huoqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387996/
https://www.ncbi.nlm.nih.gov/pubmed/32765198
http://dx.doi.org/10.1155/2020/2010924

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7387996/
https://www.ncbi.nlm.nih.gov/pubmed/32765198
http://dx.doi.org/10.1155/2020/2010924

Ejemplares similares